Unknown NA INTERVENTIONAL 1-arm NCT00793052

Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery: A Prospective, Double-Blind Study

Sponsor: Tel-Aviv Sourasky Medical Center

Conditions Edema Pain Trismus

Interventions Etodalac, Etoricoxib and Dexamethasone

Updated 6 times since 2017 Last updated: Nov 16, 2008 Started: Nov 30, 2008 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00793052, this NA trial focuses on Edema and Pain and remains ongoing. Sponsored by Tel-Aviv Sourasky Medical Center, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2017 — Jun 2018 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tel-Aviv Sourasky Medical Center

Data source: Tel-Aviv Sourasky Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.